
Cortisol
Serum Cortisol (Morning)
What it is
Cortisol is a glucocorticoid hormone produced by the adrenal cortex in response to adrenocorticotropic hormone (ACTH) from the anterior pituitary, which in turn responds to corticotropin-releasing hormone (CRH) from the hypothalamus. This hypothalamic-pituitary-adrenal (HPA) axis is the central mediator of the physiological stress response. Cortisol follows a strong circadian rhythm: it peaks within 30–45 minutes of waking (the cortisol awakening response), remains moderately elevated through the morning, and declines progressively to a nadir around midnight. The morning peak is the physiologically most informative and clinically most standardised measurement point. In the short term, cortisol mobilises glucose through glycogenolysis and gluconeogenesis, modulates immune function, and drives the alertness and metabolic activation needed to respond to acute demands — an adaptive response. Chronically elevated cortisol, reflecting persistent HPA axis activation rather than discrete acute stressors, produces a distinct and clinically significant pattern of systemic harm.
Why we measure it
The distinction between acute and chronic cortisol elevation is central to understanding its clinical relevance. Transient cortisol elevation during acute stress is physiologically normal and largely benign. Chronic elevation — sustained over months or years through psychological stress, sleep deprivation, shift work, visceral obesity, or HPA axis dysregulation — produces a cascade of adverse downstream effects. Chronically elevated cortisol promotes insulin resistance by blocking insulin signalling in peripheral tissues and stimulating hepatic gluconeogenesis, driving hyperglycaemia and eventually type 2 diabetes. It promotes visceral fat deposition specifically — and visceral fat itself elevates cortisol through local 11β-HSD1 enzymatic activity, creating a self-amplifying cycle. It suppresses immune competence, impairs hippocampal neurogenesis (contributing to memory consolidation failure and mood disruption), raises blood pressure through mineralocorticoid receptor cross-reactivity, reduces bone mineral density, and suppresses anabolic hormones including testosterone and IGF-1. Population studies have consistently linked higher morning cortisol levels and flattened diurnal cortisol slope to elevated cardiovascular risk, cognitive decline, and all-cause mortality — effects most consistently observed in middle-aged and older adults.
Why every 6 months
Morning serum cortisol, collected fasting before 9 am, is the standard clinical measurement of HPA axis basal output. The six-monthly Pulse+ draw is not designed to capture day-to-day or week-to-week cortisol variability — which requires salivary measurements, urinary free cortisol, or cortisol awakening response protocols — but rather to assess the chronic HPA axis state and its longitudinal trajectory. An individual whose morning cortisol is persistently at the upper end of the reference range across successive six-monthly measurements, and rising over time, is giving a different signal than one whose cortisol is mid-range and stable. This view contextualises the number: the trend across draws is more informative than any individual result in isolation.
What movement means
Standard laboratory reference ranges for morning serum cortisol in adults typically span 6–23 mcg/dL (166–635 nmol/L), with the understanding that values should be collected between 7 and 9 am in a fasting state. Values consistently at the upper end of this range warrant assessment of lifestyle factors — sleep quality, psychological stress load, visceral adiposity — and in clinical settings, consideration of formal HPA axis evaluation. Values below the lower end of the reference range may indicate adrenal insufficiency and warrant clinical review. The reference range describes the distribution in a population sample; it does not define the level associated with optimal health outcomes.
Low
< 6 mcg/dL (< 166 nmol/L)
Below the lower standard reference limit for morning serum cortisol. May indicate adrenal insufficiency or a non-standard collection time. Warrants clinical assessment, particularly if accompanied by symptoms of fatigue, salt craving, or orthostatic hypotension.
Standard clinical laboratory reference ranges — vary by institution and assay method
Normal
6 – 23 mcg/dL (166 – 635 nmol/L)
Within the standard reference range for morning serum cortisol (collected 7–9 am, fasting). The position and trajectory within this range — not merely the binary normal/abnormal classification — provides the most clinically useful signal over time.
Standard clinical laboratory reference ranges — vary by institution and assay method
Elevated
> 23 mcg/dL (> 635 nmol/L)
Above the upper standard reference limit. May indicate physiological stress at the time of collection, chronic HPA axis dysregulation, or, at substantially higher levels, pathological hypercortisolaemia (Cushing's syndrome). Clinical context and repeat measurement are necessary before interpretation.
Standard clinical laboratory reference ranges — vary by institution and assay method
References
- 1.
Kumari M, Shipley M, Stafford M, Kivimaki M. “Association of Diurnal Patterns in Salivary Cortisol with All-Cause and Cardiovascular Mortality: Findings from the Whitehall II Study.” Journal of Clinical Endocrinology & Metabolism. 2011.
- 2.
Rosmond R, Björntorp P. “The Hypothalamic-Pituitary-Adrenal Axis Activity as a Predictor of Cardiovascular Disease, Type 2 Diabetes and Stroke.” Journal of Internal Medicine. 2000.
- 3.
Walker BR. “Glucocorticoids and Cardiovascular Disease.” European Journal of Endocrinology. 2007.
- 4.
Steptoe A, Kunz-Ebrecht SR, Brydon L, Wardle J. “Central Adiposity and Cortisol Responses to Waking in Middle-Aged Men and Women.” International Journal of Obesity. 2004.